Diagnos Laboratorium Utama Tbk. vs Manggung Polahraya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Manggung Polahraya Tbk. trades at Rp37 (market cap 141.07B, 1.86M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.2× Manggung Polahraya Tbk.'s market cap, and Manggung Polahraya Tbk. is more actively traded (1.86M versus 27.5K). Which is the better fit depends on your goals.
| DGNS | MANG | |
|---|---|---|
Market Cap | 308B | 141.07B |
Volume | 27.5K | 1.86M |
Lot | 275 | 18.62K |
Turnover | 6.23M | 69.56M |
Average Price | 226.59 | 37.35 |
Value | 6.23M | 69.56M |
Indicative Equilibrium Price | 230 | — |
Indicative Equilibrium Volume | 110 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Manggung Polahraya Tbk (Company) was established in Jakarta based on notarial deed No. 3 dated February 5, 1992, which was made by Esther Mercia Sulaiman, S.H., notary in Cianjur.
Read more on MANG →